A synergistic combination of a GHRH analog (Tesamorelin) and a selective ghrelin receptor agonist (Ipamorelin). This dual mechanism amplifies pulsatile growth hormone release from the pituitary, promoting visceral fat reduction, enhanced protein synthesis, improved recovery, and optimized body composition with minimal side effects.
